Method
Level · gp.fundamentals.debt_to_revenue
Raw value 251.69% · OPTIONAL
· Pharmaceutical Preparations
RESEARCH SNAPSHOTEmergent BioSolutions Inc.'s latest supported as-filed period reports revenue of $234.3M, 66.3% above the comparable as-filed period. Every value below links to its SEC accession and metric lineage.
No material rule-based research observation currently meets GrossPattern's Insight value threshold. Current state, direction, and filing evidence remain available below.
A multidimensional view of the latest comparable filing—not a composite score or recommendation.
Level · gp.fundamentals.debt_to_revenue
Raw value 251.69% · OPTIONAL
Level · gp.fundamentals.capex_revenue_ratio
Raw value 0.90% · OPTIONAL
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
Raw value 23.94% · OPTIONAL
Yoy · gp.fundamentals.revenue
Raw value 66.29% · CORE
Level · gp.fundamentals.inventory_revenue_ratio
Raw value 129.58% · OPTIONAL
Level · gp.fundamentals.operating_margin
Raw value -53.39% · CORE
Business direction, financial quality, capital allocation, and governance evidence remain separate—never collapsed into a recommendation score.
Interpretation boundary Direction describes measurable company fundamentals. Governance reports observable evidence only; it does not grade management character or predict stock returns.
Latest available comparable states within 180 days, normalized with robust median/MAD statistics.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
This cluster groups 3 independently calculated changes: Revenue increased 66.3%; Operating margin moved 5453 bp lower; Operating income changed across a sign change.
3 evidence-backed componentsRevenue changed +66.3% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Each point keeps the date investors could first observe it and its accession.
EBS · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001367644-26-000088SEC ↗10-QAug 6, 2026Period Jun 30, 20260001367644-26-000082SEC ↗8-KAug 5, 2026Period Aug 5, 20260001367644-26-000080SEC ↗4Jul 2, 2026Period Jul 1, 20260001961994-26-000024SEC ↗8-KJun 29, 2026Period Jun 26, 20260001367644-26-000068SEC ↗4Jun 10, 2026Period Jun 8, 20260001961994-26-000021SEC ↗4Jun 10, 2026Period Jun 8, 20260001196632-26-000017SEC ↗Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
| Filed / transacted | Reporting owner | Semantics | Shares | Price | Notional | Source |
|---|---|---|---|---|---|---|
| Jul 1, 2026Filed Jul 2, 2026 | Williams Paul AnthonySVP, Products Business | Open Market SaleDirect | 3,000 | $8 | $25,200 | Form 4 ↗ |
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
Raw value 3.93% · OPTIONAL
Level · gp.fundamentals.sbc_revenue_ratio
Raw value 2.94% · OPTIONAL
Inventory changed -10.3% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Operating margin changed -5453 basis points from the comparable as-filed period.
Inventory / revenue changed -11073 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Cash & equivalents changed -47.7% from the comparable as-filed period.
Net income changed -1401.7% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a low base. This reverses 2 consecutive comparable moves in the opposite direction.
Debt changed -15.8% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-06-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001919170-26-000016